These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

671 related items for PubMed ID: 29724506

  • 1. Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program.
    Garland SM, Cornall AM, Brotherton JML, Wark JD, Malloy MJ, Tabrizi SN, VACCINE study group.
    Vaccine; 2018 May 31; 36(23):3221-3230. PubMed ID: 29724506
    [Abstract] [Full Text] [Related]

  • 2. Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program.
    Osborne SL, Tabrizi SN, Brotherton JM, Cornall AM, Wark JD, Wrede CD, Jayasinghe Y, Gertig DM, Pitts MK, Garland SM, VACCINE Study group.
    Vaccine; 2015 Jan 01; 33(1):201-8. PubMed ID: 25444787
    [Abstract] [Full Text] [Related]

  • 3. Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy.
    Carozzi F, Puliti D, Ocello C, Anastasio PS, Moliterni EA, Perinetti E, Serradell L, Burroni E, Confortini M, Mantellini P, Zappa M, Dominiak-Felden G.
    BMC Infect Dis; 2018 Jan 15; 18(1):38. PubMed ID: 29334901
    [Abstract] [Full Text] [Related]

  • 4. Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada.
    Goggin P, Sauvageau C, Gilca V, Defay F, Lambert G, Mathieu-C S, Guenoun J, Comète E, Coutlée F.
    Hum Vaccin Immunother; 2018 Jan 02; 14(1):118-123. PubMed ID: 29049007
    [Abstract] [Full Text] [Related]

  • 5. Asking about human papillomavirus vaccination and the usefulness of registry validation: a study of young women recruited using Facebook.
    Gunasekaran B, Jayasinghe Y, Brotherton JM, Fenner Y, Moore EE, Wark JD, Fletcher A, Tabrizi SN, Garland SM.
    Vaccine; 2015 Feb 04; 33(6):826-31. PubMed ID: 25444782
    [Abstract] [Full Text] [Related]

  • 6. Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study.
    Tabrizi SN, Brotherton JM, Kaldor JM, Skinner SR, Liu B, Bateson D, McNamee K, Garefalakis M, Phillips S, Cummins E, Malloy M, Garland SM.
    Lancet Infect Dis; 2014 Oct 04; 14(10):958-66. PubMed ID: 25107680
    [Abstract] [Full Text] [Related]

  • 7. Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study.
    Chow EPF, Machalek DA, Tabrizi SN, Danielewski JA, Fehler G, Bradshaw CS, Garland SM, Chen MY, Fairley CK.
    Lancet Infect Dis; 2017 Jan 04; 17(1):68-77. PubMed ID: 27282422
    [Abstract] [Full Text] [Related]

  • 8. Human papillomavirus prevalence and risk factors among Australian women 9-12 years after vaccine program introduction.
    Shilling H, Garland SM, Atchison S, Cornall AM, Brotherton JML, Bateson D, McNamee K, Kaldor JM, Hocking JS, Chen MY, Fairley CK, McNulty A, Bell C, Marshall L, Ooi C, Skinner SR, Murray G, Molano M, Tabrizi S, Machalek DA.
    Vaccine; 2021 Aug 09; 39(34):4856-4863. PubMed ID: 34281743
    [Abstract] [Full Text] [Related]

  • 9. Quadrivalent human papillomavirus vaccination successfully reduces the prevalence of vaccine-targeted genotypes in a young, vaccine-eligible-age sample of Australian females.
    Subasinghe AK, Wark JD, Phillips S, Cornall A, Brotherton JML, Garland SM.
    Sex Health; 2020 Dec 09; 17(6):510-516. PubMed ID: 33341122
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of human papillomavirus in young men who have sex with men after the implementation of gender-neutral HPV vaccination: a repeated cross-sectional study.
    Chow EPF, Tabrizi SN, Fairley CK, Wigan R, Machalek DA, Garland SM, Cornall AM, Atchison S, Hocking JS, Bradshaw CS, Balgovind P, Murray GL, Chen MY.
    Lancet Infect Dis; 2021 Oct 09; 21(10):1448-1457. PubMed ID: 34043963
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of human papillomavirus in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia: 2014-2017.
    Chow EPF, Tabrizi SN, Fairley CK, Wigan R, Machalek DA, Regan DG, Hocking JS, Garland SM, Cornall AM, Atchison S, Bradshaw CS, McNulty A, Owen L, Marshall L, Russell DB, Kaldor JM, Chen MY.
    Vaccine; 2019 Oct 31; 37(46):6907-6914. PubMed ID: 31562001
    [Abstract] [Full Text] [Related]

  • 12. Monitoring human papillomavirus prevalence among young Australian women undergoing routine chlamydia screening.
    Shilling H, Murray G, Brotherton JML, Hawkes D, Saville M, Sivertsen T, Chambers I, Roberts J, Farnsworth A, Garland SM, Hocking JS, Kaldor J, Guy R, Atchison S, Costa AM, Molano M, Machalek DA.
    Vaccine; 2020 Jan 29; 38(5):1186-1193. PubMed ID: 31767467
    [Abstract] [Full Text] [Related]

  • 13. Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study.
    Chow EP, Danielewski JA, Fehler G, Tabrizi SN, Law MG, Bradshaw CS, Garland SM, Chen MY, Fairley CK.
    Lancet Infect Dis; 2015 Nov 29; 15(11):1314-23. PubMed ID: 26201300
    [Abstract] [Full Text] [Related]

  • 14. Age and geographic variability of human papillomavirus high-risk genotype distribution in a large unvaccinated population and of vaccination impact on HPV prevalence.
    Carozzi F, De Marco L, Gillio-Tos A, Del Mistro A, Girlando S, Baboci L, Trevisan M, Burroni E, Grasso S, Giorgi Rossi P, Ronco G, NTCC Working Group.
    J Clin Virol; 2014 Jul 29; 60(3):257-63. PubMed ID: 24815381
    [Abstract] [Full Text] [Related]

  • 15. HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program.
    Tabrizi SN, Brotherton JM, Stevens MP, Condon JR, McIntyre P, Smith D, Garland SM, WHINURS group.
    J Clin Virol; 2014 Jul 29; 60(3):250-6. PubMed ID: 24854516
    [Abstract] [Full Text] [Related]

  • 16. Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study.
    McGregor S, Saulo D, Brotherton JML, Liu B, Phillips S, Skinner SR, Luey M, Oliver L, Stewart M, Tabrizi SN, Garland S, Kaldor JM.
    Vaccine; 2018 Jul 05; 36(29):4311-4316. PubMed ID: 29880245
    [Abstract] [Full Text] [Related]

  • 17. Attitudes, Knowledge and Factors Associated with Human Papillomavirus (HPV) Vaccine Uptake in Adolescent Girls and Young Women in Victoria, Australia.
    Tung IL, Machalek DA, Garland SM.
    PLoS One; 2016 Jul 05; 11(8):e0161846. PubMed ID: 27564213
    [Abstract] [Full Text] [Related]

  • 18. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER, Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 2007 Mar 23; 56(RR-2):1-24. PubMed ID: 17380109
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of Human Papillomavirus Vaccination on Prevalence of Vaccine Genotypes in Young Sexually Active Women in France.
    Heard I, Tondeur L, Arowas L, Demazoin M, Falguières M, Parent Du Chatelet I, pour le groupe CHlaHPV.
    J Infect Dis; 2017 Mar 01; 215(5):757-763. PubMed ID: 28011911
    [Abstract] [Full Text] [Related]

  • 20. Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda.
    Kumakech E, Berggren V, Wabinga H, Lillsunde-Larsson G, Helenius G, Kaliff M, Karlsson M, Kirimunda S, Musubika C, Andersson S.
    PLoS One; 2016 Mar 01; 11(8):e0160099. PubMed ID: 27482705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.